Should You Buy Ares Capital (ARCC) Stock Before February?

Ares Capital (ARCC), the largest BDC with a $28.7bn portfolio across 587 companies, yields 9.6% and trades near NAV ($20.01) at roughly $20 per share (~10x next year's earnings). EPS surged from $1.19 in 2022 to $2.68 in 2023 but fell 21% to $2.44 in 2024; analysts forecast another ~21% decline to $1.94 in 2025, roughly covering the $1.92 forward dividend, with EPS ~ $1.95 in 2026 and $1.92 in 2027. Management maintains conservative leverage (net debt/equity ~1.02 as of Q3 2025) and the firm’s high yield plus low valuation suggests limited downside though declining rates will likely cap near-term upside, so the recommendation is to nibble for income but await earnings commentary before adding larger positions.

Analysis

Market structure: Lower Fed rates strip net interest income from floating-rate BDCs like ARCC even as credit quality of middle‑market borrowers slowly improves. ARCC’s heavy first‑lien mix (61.6%) and broad 587‑company diversification limits idiosyncratic loss but compresses yield sensitivity — at $20/share, 9.6% forward yield and NAV ~$20 implies limited downside but capped upside absent rate stabilization (target price range $20–$24 over 12 months).

Risk assessment: Tail risks include a recession-driven default spike that forces NAV markdowns >10%, or a regulatory change to BDC tax/treatment; both could prompt dividend cuts (trigger if EPS < $1.92 sustained). Immediate risk window: Feb earnings and 30‑60 day Fed communications; medium term: two Fed cuts priced into 2026 — if cuts accelerate, expect NII to drop 10–25% vs 2023 highs and slower EPS recovery.

Trade implications: Tactical income buyers can nibble ARCC but size positions (<3% portfolio) because upside is muted; use protective hedges around Feb earnings. Relative trades favor ARCC vs higher‑duration/weaker‑collateral BDC peers (long ARCC, short weaker BDC) and options trades (sell covered calls, buy OTM puts) to monetize the 9.6% yield while capping tail loss.

Contrarian angles: Consensus understates dividend fragility — EPS estimates (~$1.94 in 2025) leave only ~1–2 cents cushion above the $1.92 dividend, so a small earnings miss can force policy action. Conversely, market may be pricing in deeper asset deterioration than warranted; if Fed pauses cuts and IG spreads tighten 50–100bp, ARCC could re‑rate towards a 10–12x forward P/E and compress yield premium.

Key Decisions for Investors

• Establish a small income position: initiate 2–3% portfolio long in ARCC at ≤ $20.20 (≈NAV+1%), target 12‑month upside to $24 (~20%) plus 9.6% yield; set hard stop at $17 (≈‑15%) or exit if reported EPS < $1.92 for two consecutive quarters.
• Hedge and income overlay: if owning ARCC, sell 1–2 month covered calls ~12% OTM (strike ≈ $22.50 on $20 entry) and purchase 3‑month puts ~7–10% OTM (≈$18–$19) to cap a tail loss while collecting premium; net cost should not exceed 1–2% annualized income drag.
• Relative value pair: long ARCC (2% weight) paired with short weaker‑collateral BDC (equal notional, e.g., GSBD or similar) to exploit ARCC’s first‑lien bias; close pair if NAV discount differential narrows to <3% or after 90 days.
• Catalyst triggers to act: materially add (>1–2% incremental) only if (a) Feb earnings confirm dividend cover (EPS ≥ $2.00) or (b) 10‑yr Treasury rise >50bp from current levels (which would widen BDC spreads); liquidate or reduce if NAV declines >7% QoQ or EPS falls below $1.92.